121 related articles for article (PubMed ID: 24604674)
1. Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions.
Yamamoto Y; Shiraishi M; Fujita M; Kojima I; Tanaka Y; Tachibana S
Mol Cell Biochem; 2014 Jun; 391(1-2):217-24. PubMed ID: 24604674
[TBL] [Abstract][Full Text] [Related]
2. A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells.
Shiraishi M; Yamamoto Y; Hirooka N; Obuchi Y; Tachibana S; Makishima M; Tanaka Y
Endocr J; 2015; 62(5):431-40. PubMed ID: 25787723
[TBL] [Abstract][Full Text] [Related]
3. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
4. Specific erythroid differentiation of mouse erythroleukemia cells by activins and its enhancement by retinoic acids.
Uchiyama H; Asashima M
Biochem Biophys Res Commun; 1992 Aug; 187(1):347-52. PubMed ID: 1520319
[TBL] [Abstract][Full Text] [Related]
5. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the Na+,K(+)-ATPase activity of K562 human erythroleukemia cells by triiodothyronine.
Arumanayagam M; Swaminathan R
Life Sci; 1992; 51(25):1913-20. PubMed ID: 1333560
[TBL] [Abstract][Full Text] [Related]
7. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
Huang HM; Chiou HY; Chang JL
J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
[TBL] [Abstract][Full Text] [Related]
8. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
Yamashita T; Eto Y; Shibai H; Ogata E
Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.
Hirase N; Yanase T; Mu Y; Muta K; Umemura T; Takayanagi R; Nawata H
Leuk Res; 2000 May; 24(5):393-400. PubMed ID: 10785261
[TBL] [Abstract][Full Text] [Related]
10. [Hypoxia promotes erythroid differentiation of human K562 cells by upregulating endothelial PAS domain-containing protein 1 (EPAS1) expression].
Gao Z; Xiao J; Li X; Li C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jun; 38(6):494-500. PubMed ID: 35732606
[TBL] [Abstract][Full Text] [Related]
11. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
[TBL] [Abstract][Full Text] [Related]
12. Inducers of erythroid differentiation in K562 human leukemia cells.
Rowley PT; Ohlsson-Wilhelm BM; Farley BA; LaBella S
Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756
[TBL] [Abstract][Full Text] [Related]
13. Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.
Huang HM; Li YC; Chung MH
J Cell Physiol; 2010 Jun; 223(3):687-94. PubMed ID: 20162623
[TBL] [Abstract][Full Text] [Related]
14. [Effect of MiR-451a on Erythroid Differentiation of K562 Cells under Hypoxia].
Hu CY; Zhang HJ; Fu CB; Liu F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2071-2078. PubMed ID: 33283744
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions.
Zhang FL; Shen GM; Liu XL; Wang F; Zhao YZ; Zhang JW
J Cell Mol Med; 2012 Aug; 16(8):1889-99. PubMed ID: 22050843
[TBL] [Abstract][Full Text] [Related]
16. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.
Huang HM; Chang TW; Liu JC
Biochem Biophys Res Commun; 2004 Aug; 320(4):1247-52. PubMed ID: 15249224
[TBL] [Abstract][Full Text] [Related]
18. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
19. Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib.
Huang YW; Lee WH; Tsai YH; Huang HM
Am J Physiol Cell Physiol; 2014 Jan; 306(1):C37-44. PubMed ID: 24088895
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miR-486 regulates hypoxia-induced erythroid differentiation of erythroleukemia cells through targeting Sirt1.
Shi XF; Wang H; Kong FX; Xu QQ; Xiao FJ; Yang YF; Ge RL; Wang LS
Exp Cell Res; 2017 Feb; 351(1):74-81. PubMed ID: 28043832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
